Anti-Hu CD18 APC

CAT:
270-1A-216-T100
Size:
100 Tests
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Anti-Hu CD18 APC - image 1

Anti-Hu CD18 APC

  • Description:

    CD18, integrin beta2 subunit, forms heterodimers with four types of CD11 molecule to constitute leukocyte (beta2) integrins: alphaLbeta2 (CD11a/CD18, LFA-1), alphaMbeta2 (CD11b/CD18, Mac-1, CR3), alphaXbeta2 (CD11c/CD18) and alphaDbeta2 (CD11d/CD18) . In most cases, the response mediated by the integrin is a composite of the functions of its individual subunits. These integrins are essential for proper leukocyte migration, mediating intercellular contacts. Absence of CD18 leads to leukocyte adhesion deficiency-1; severe reduction of CD18 expression leads to the development of a psoriasiform skin disease. CD18 is also a target of Mannheimia (Pasteurella) haemolytica leukotoxin and is sufficient to mediate leukotoxin-mediated cytolysis.
  • Certification:

    RUO
  • Negative Species:

    Dog
  • Immunogen:

    Leukocytes of a patient suffering from a LGL-type leukemia.
  • Target Antigen:

    CD18
  • Clone:

    MEM-48
  • Applications:

    FC (QC tested)
  • Format:

    APC
  • Buffer:

    Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
  • References & Citations:

    *Kuttruff S, Koch S, Kelp A, Pawelec G, Rammensee HG, Steinle A: NKp80 defines and stimulates a reactive subset of CD8 T cells. Blood. 2009 Jan 8;113 (2) :358-69., URL: http://www.ncbi.nlm.nih.gov/pubmed/18922855 , *Schiff DE, Rae J, Martin TR, Davis BH, Curnutte JT: Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood. 1997 Oct 15;90 (8) :3187-94., URL: http://www.ncbi.nlm.nih.gov/pubmed/9376602 , *Ottonello L, Epstein AL, Dapino P, Barbera P, Morone P, Dallegri F: Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: intervention of FcgammaRII (CD32), CD11b-CD18 integrins, and CD66b glycoproteins. Blood. 1999 May 15;93 (10) :3505-11., URL: http://www.ncbi.nlm.nih.gov/pubmed/10233903?itool=, *Garnotel R, Rittié L, Poitevin S, Monboisse JC, Nguyen P, Potron G, Maquart FX, Randoux A, Gillery P: Human blood monocytes interact with type I collagen through alpha x beta 2 integrin (CD11c-CD18, gp150-95) . J Immunol. 2000 Jun 1;164 (11) :5928-34., URL: http://www.ncbi.nlm.nih.gov/pubmed/10820275?itool=, *Stefanova I, Horejsi V: Association of the CD59 and CD55 cell surface glycoproteins with other membrane molecules. J Immunol. 1991 Sep 1;147 (5) :1587-92. , URL: https://www.ncbi.nlm.nih.gov/pubmed/1715364?dopt=A, *Larson RS, Springer TA: Structure and function of leukocyte integrins. Immunol Rev. 1990 Apr;114:181-217., URL: , *Bazil V, Stefanova I, Hilgert I, Kristofova H, Vanek S, Horejsi V.: Monoclonal antibodies against human leucocyte antigens. IV. Antibodies against subunits of the LFA-1 (CD11a/CD18) leucocyte-adhesion glycoprotein. Folia Biol (Praha) . 1990;36 (1) :41-50., URL: https://www.ncbi.nlm.nih.gov/pubmed/1971601?dopt=A
  • Other References:

    *Dassanayake RP, Maheswaran SK, Srikumaran S: Monomeric expression of bovine beta2-integrin subunits reveals their role in Mannheimia haemolytica leukotoxin-induced biological effects. Infect Immun. 2007 Oct;75 (10) :5004-10., URL: https://pubmed.ncbi.nlm.nih.gov/17698568/, *Peters T, Sindrilaru A, Wang H, Oreshkova T, Renkl AC, Kess D, Scharffetter-Kochanek K: CD18 in monogenic and polygenic inflammatory processes of the skin. J Investig Dermatol Symp Proc. 2006 Sep;11 (1) :7-15., URL: https://pubmed.ncbi.nlm.nih.gov/17069006/, *Solovjov DA, Pluskota E, Plow EF: Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem. 2005 Jan 14;280 (2) :1336-45., URL: https://pubmed.ncbi.nlm.nih.gov/15485828/, *Kess D, Peters T, Zamek J, Wickenhauser C, Tawadros S, Loser K, Varga G, Grabbe S, Nischt R, Sunderkötter C, Müller W, Krieg T, Scharffetter-Kochanek K: CD4+ T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine model of psoriasis. J Immunol. 2003 Dec 1;171 (11) :5697-706., URL: https://pubmed.ncbi.nlm.nih.gov/14634077/, *Shang XZ, Issekutz AC: Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers. Eur J Immunol. 1998 Jun;28 (6) :1970-9., URL: https://pubmed.ncbi.nlm.nih.gov/9645379/, *Drbal K, Angelisova P, Cerny J, Pavlistova D, Cebecauer M, Novak P, Horejsi V: Human leukocytes contain a large pool of free forms of CD18. Biochem Biophys Res Commun. 2000 Aug 28;275 (2) :295-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/10964661?dopt=, *Gao JX, Issekutz AC: Mac-1 (CD11b/CD18) is the predominant beta 2 (CD18) integrin mediating human neutrophil migration through synovial and dermal fibroblast barriers. Immunology. 1996 Jul;88 (3) :463-70., URL: https://pubmed.ncbi.nlm.nih.gov/8774366/
  • Storage Conditions:

    Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
  • Specificity:

    The antibody MEM-48 recognizes an extracellular epitope involving residues 534-546 in cysteine-rich repeat 3 of the CD18 antigen (integrin beta2 subunit; beta2 integrin) . CD18 is a 90-95 kDa type I transmembrane protein expressed on all leukocytes.
  • Applications Notes:

    6
  • Species:

    Human
  • CAS Number:

    9007-83-4
  • Isotype:

    Mouse IgG1